Article | March 21, 2024

Building Biopharma Resilience In Developing Gene Therapies

Source: Cytiva
Leszek Lisowski
Leszek Lisowski

Leszek Lisowski, an Associate Professor at the University of Sydney and Children’s Medical Research Institute, plays a crucial role in advancing the development of gene therapies aimed at treating rare and serious diseases. Here, he shares his perspectives on how government entities and the biopharmaceutical industry can support his groundbreaking work.
Learn about the opportunities and challenges surrounding gene therapies, the importance of collaboration between biopharma startups and academia to bring better therapies to patients, difficulties with the talent pipeline, and more.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Biosimilar Development